U.S. stock futures edged up on Friday as investors monitored Iran ceasefire developments awaiting Trump approval. Major indexes posted modest gains with healthcare, IT, and consumer discretionary leading. Dell surged nearly 40% on strong earnings, while Agilent and Hewlett Packard Enterprise also gained. Costco reported mixed results with earnings slightly below estimates. The Fed is expected to hold rates steady in June with 98.9% probability.

Agilent Technologies stock surged 17.25% on Thursday following strong Q2 2026 earnings results. The company reported $1.83 billion in revenue (up 10% YoY) and $1.49 per share in adjusted net income (up 14% YoY), beating analyst expectations on both metrics. All three business segments showed growth, with Applied Markets Group leading at 14%. Management raised full-year 2026 guidance for both revenue and adjusted net income.

U.S. stocks reached record highs on Thursday following geopolitical news of a ceasefire extension. The S&P 500 advanced 0.5% to 7,557.85, driven by an AI software spending spree. Snowflake surged 37% after beating earnings estimates and announcing a $6 billion AWS partnership expansion. Other notable gainers included Best Buy (+18%), Dollar Tree (+17%), and Agilent Technologies (+17%). However, mixed economic data showed headline PCE inflation at 3.8% while core PCE and consumer spending remained subdued, prompting hawkish Fed commentary.

The global tissue diagnostics market is projected to grow from USD 6.45 billion in 2025 to USD 9.33 billion by 2031, with a CAGR of 6.35%. Growth is driven by increasing cancer prevalence, rising adoption of precision medicine, advancements in digital pathology and AI-assisted diagnostics, and expanding biomarker-based testing. North America leads the market while Asia-Pacific emerges as a high-growth region.

The global DNA microarray market is expected to grow from USD 2.5 billion in 2025 to USD 4.7 billion by 2034 at a CAGR of ~7%. Growth is driven by rising demand for genomic research, personalized medicine, early disease diagnosis, and increasing prevalence of cancer and genetic disorders. North America leads the market with 41.39% share, while Asia-Pacific emerges as a key growth contributor.

The global NGS market is projected to reach USD 29.53 billion by 2030 from USD 14.94 billion in 2025, growing at a CAGR of 14.6%. Growth is driven by expanding applications in oncology, infectious diseases, and precision medicine, with Asia-Pacific exhibiting the fastest regional growth. Consumables dominate the product segment, while academic and research institutes lead the services end-user segment.

Multiple major M&A transactions are underway across various sectors. Papa John's received a $1.5 billion privatization proposal from Irth Capital Management backed by Brookfield Asset Management. Shell sold Jiffy Lube to Monomoy Capital Partners for $1.3 billion. Meta acquired AI social network Moltbook, while Google completed its $32 billion acquisition of cloud security platform Wiz. Other notable deals include Agilent acquiring Biocare Medical for $950 million and Universal Health Services acquiring Talkspace for $835 million. Meanwhile, several retailers including Eddie Bauer and Saks Global are closing stores amid bankruptcy proceedings.

The global molecular diagnostics market is projected to reach USD 33.51 billion by 2031, growing at a CAGR of 10.43% from 2026 to 2031. Growth is driven by increasing adoption of precision medicine, advancements in genomic testing technologies, and rising prevalence of infectious and chronic diseases. North America leads the market while Asia-Pacific is expected to be the fastest-growing region.

Agilent Technologies announced the acquisition of Biocare Medical for approximately $950 million to strengthen its pathology and immunohistochemistry offerings. The deal is expected to close by Q4 fiscal 2026 and become accretive to EPS within 12 months. However, Agilent's stock has declined 5.60% over the past year and is currently trading below key moving averages, showing weak momentum despite the strategic acquisition.

The global microplate systems market was valued at USD 1.42 billion in 2025 and is projected to reach USD 2.88 billion by 2035, growing at a CAGR of 10.7%. Growth is driven by increased R&D spending in pharmaceuticals, rising demand for high-throughput screening in drug discovery, and innovations in multimode detection systems and automation. Key players include Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer, and Bio-Rad Laboratories.

The global chromatography market is projected to grow from USD 10.03 billion in 2025 to USD 13.69 billion by 2031 at a CAGR of 5.32%, driven by expanding R&D in pharma/biotech and strict food safety regulations. However, high capital costs limit adoption among smaller entities. Emerging trends include green chromatography and AI-powered method optimization.

The global automated sample preparation market is expected to expand at a 10.10% CAGR from 2025 to 2031, driven by pharmaceutical R&D investments, need for reproducibility, and AI/ML adoption. However, high initial costs and integration challenges with legacy systems remain significant barriers, particularly for smaller laboratories and SMEs.